Filing Details
- Accession Number:
- 0001140361-17-044911
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-04 18:00:18
- Reporting Period:
- 2017-11-30
- Accepted Time:
- 2017-12-04 18:00:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1500399 | Giovani Twigge | Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092 | Chief Human Resources Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-11-30 | 1,442 | $156.09 | 14,960 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-30 | 558 | $156.01 | 14,402 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the weighted average sales price of the shares sold ranging from a low of $156.05 to a high of $156.155 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Includes a total of 70 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2017 and September 29, 2017.